PGEA1 Products

Description

Position of the Chimera RNAi. The related RNAi products listed were designed from different accesion number but sharing the same RNAi sequence. Chimera RNA interference (chimera RNAi) is process by which small interfering RNA/DNA chimera triggers the destruction of mRNA for the original gene.  The discovery work, design, and application of chimera RNAi has been pioneered by Professor Kaoru Saigo and Dr. Kumiko Ui-Tei at the University of Tokyo.  Chimera RNAi has many advantages over the conventional siRNAs.  First, it has been demonstrated to have reliable knock-down for over 10,000 human genes.  Because the human genome is composed of an intricate, genetic network, chimera RNAi's unique design has successfully obviated the off-target effects including microRNA-based influence.  Another advantage of the chimera RNAi technology is its effectiveness at low concentrations (0.5nM to 5nM); only mRNA is destroyed so genomic genes are not affected.  Finally, having both the sense and anti-sense strands consisting RNA/DNA chimera, it offers much greater compound stability for streamlining in vitro and in vivo assays and applications while minimizing interferon induction and other adverse reactions.

Bioinformatics

Product By Gene ID

25776

Alternate Names

arb1 ARPP-binding protein C22orf2chromosome 22 open reading frame 2 Cby CBYgolgi and endoplasmic reticulum associated 1 chibby homolog 1 (Drosophila) coiled-coil protein PIGEA-14 Cytosolic leucine-rich protein HS508I15A PGEA1 PIGEA-14Chibby PKD2 interactor, Golgi and endoplasmic reticulum-associated 1 polycystin-2 interactor, Golgi- and endoplasmic reticulum-associated protein protein chibby homolog 1

Research Areas for PGEA1

Find related products by research area and learn more about each of the different research areas below.

Golgi Apparatus Markers